T 1118/12 (Immune-compromised patient/GLAXOSMITHKLINE) of 01.03.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T111812.20160301
- Date of decision
- 1 March 2016
- Case number
- T 1118/12
- Petition for review of
- -
- Application number
- 02806591.0
- IPC class
- A61K 39/116
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Glycoconjugate vaccines for use in immune-compromised populations
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Novelty - (yes)
Inventive step - (no) - Catchword
- -
Order
For these reasons it is decided that:
The appeal is dismissed.